REVIEW ARTICLE
Year : 2022 | Volume
: 8 | Issue : 2 | Page : 55--58
Bilastine up-dosing in chronic urticaria: A review
Kiran Godse1, Murlidhar Rajagopalan2, Bela Shah3, Mukesh Girdhar4, Kupra Shankar5, Vijay Zawar6, Abhishek De7, Nidhi Sharma8, Sushil Tahiliani9, Anant Patil10
1 Department of Dermatology, Dr. DY Patil Medical College, Nerul, Navi Mumbai Maharashtra, India
2 Department of Dermatology, Apollo Hospital, Chennai, India
3 Department of Dermatology, BJ Medical College, Ahmedabad, Gujarat, India
4 Department of Dermatology, Max Super Speciality Hospital, New Delhi, India
5 Department of Dermatology, Krupa Shankar Skin Care Center, Mallige Hospital, Bengaluru, Karnataka, India
6 Department of Dermatology, Skin Diseases Center, Nashik, India
7 Department of Dermatology, Calcutta National Medical College, Kolkata, West Bengal, India
8 Department of Dermatology, The Medicity, Medanta Hospital, Gurugram, Haryana, India
9 Department of Dermatology, Hinduja Hospital, Mumbai, India
10 Department of Pharmacology, Dr. DY Patil Medical College, Nerul, Navi Mumbai, Maharashtra, India
Correspondence Address:
Kiran Godse
Department of Dermatology, Dr. DY Patil Medical College, Nerul, Navi Mumbai Maharashtra
India
Chronic urticaria, a heterogenous skin condition can be difficult to treat in many patients. It can adversely affect patient’s quality of life. Bilastine is a useful armamentarium for the management of chronic urticaria. This second generation H1 antihistamine is distinguished from most of its counterparts. Non-sedating potential, fast onset and longer duration of action, less risk of drug interactions and once daily administration make it an attractive option for use. In patients with chronic urticaria, not showing satisfactory response to standard doses, its dose can be increased up to four fold. In this review, we discuss the evidence of higher dose of bilastine in chronic urticaria and its place in therapy.
How to cite this article:
Godse K, Rajagopalan M, Shah B, Girdhar M, Shankar K, Zawar V, De A, Sharma N, Tahiliani S, Patil A. Bilastine up-dosing in chronic urticaria: A review.Indian J Drugs Dermatol 2022;8:55-58
|
How to cite this URL:
Godse K, Rajagopalan M, Shah B, Girdhar M, Shankar K, Zawar V, De A, Sharma N, Tahiliani S, Patil A. Bilastine up-dosing in chronic urticaria: A review. Indian J Drugs Dermatol [serial online] 2022 [cited 2023 May 28 ];8:55-58
Available from: https://www.ijdd.in/article.asp?issn=2455-3972;year=2022;volume=8;issue=2;spage=55;epage=58;aulast=Godse;type=0 |
|
